A comparative analysis of patients with early-onset vs late-onset nosocomial pneumonia in the ICU setting

Chest

Volumn 117, Issue 5, 2000, Pages 1434-1442

  Ibrahim, Emad H ^a   Ward, Suzanne ^a   Sherman, Glenda ^b   Kollef, Marin H ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BARNES JEWISH HOSPITAL   (United States)

Author keywords

Clinical outcomes; Critical care; Hospital mortality; ICU; Infection; Nosocomial pneumonia; Risk factors

Indexed keywords

ANTIBIOTIC AGENT;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CRITICAL ILLNESS; DISEASE COURSE; ENTEROBACTER; FEMALE; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PNEUMONIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; STENOTROPHOMONAS MALTOPHILIA;

EID: 0034110486     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.117.5.1434     Document Type: Article

References (40)

1. 1 George DL. Epidemiology of nosocomial pneumonia in intensive care unit patients. Clin Chest Med 1995; 16:29-44
2. 2 Kollef MH, Silver P, Murphy DM, et al. The effect of late-onset ventilator-associated pneumonia in determining patients mortality. Chest 1995; 108:1655-1662
3. 3 Kollef MH. The prevention of ventilator-associated pneumonia. N Engl J Med 1999; 340:627-634
4. 4 American Thoracic Society. Hospital-acquired pneumonia in adults: diagnosis, assessment of severity, initial antimicrobial therapy, and preventive strategies. Am J Respir Crit Care Med 1996; 153:1711-1725
5. 5 Bowton DL. Nosocomial pneumonia in the ICU-year 2000 and beyond. Chest 1999; 115(suppl):28S-33S
6. 6 McEachern R, Campbell GD Jr. Hospital-acquired pneumonia: epidemiology, etiology, and treatment. Infect Dis Clin North Am 1998; 12:761-779
7. 7 Wunderink RG. Therapy for nosocomial pneumonia. Curr Opin Pulm Med 1997; 3:120-124
8. 8 Trouillet JL, Chastre J, Vuagnat A, et al. Ventilator-associated pneumonia caused by potentially drug-resistant bacteria. Am J Respir Crit Care Med 1998; 157:531-539
9. 9 Craven DE, Steger KA. Ventilator-associated bacterial pneumonia: challenge in diagnosis, treatment, and prevention. New Horiz 1998; 6(2 suppl):30S-35S
10. 10 Knaus WA, Wagner DP, Draper EA, et al. The APACHE II prognostic system: risk prediction of hospital mortality for critically ill hospitalized adults. Chest 1991; 100:1619-1636
11. 11 Rubin DB, Wiener-Kronish JP, Murray JF, et al. Elevated von Willebrand factor antigen is an early phase predictor of acute lung injury in nonpulmonary sepsis syndrome. J Clin Invest 1990; 86:474-480
12. 12 Pingleton SK, Fagon JY, Leeper KV Jr. Patient selection for clinical investigation of ventilator-associated pneumonia: criteria for evaluating diagnostic techniques. Chest 1992; 102: 553S-556S
13. 13 Kollef MH, Bock KR, Richards RD, et al. The safety and diagnostic accuracy of minibronchoalveolar lavage in patients with suspected ventilator-associated pneumonia. Ann Intern Med 1995; 122:743-748
14. 14 Hosmer DW, Lemeshow S. Applied logistic regression. 1st ed. New York, NY: Wiley Interscience Publication, 1989; 25-81
15. 15 SAS/STAT user's guide. Vol 2. Cary, NC: SAS Institute, 1990; 1071-1126
16. 16 Concato J, Feinstein AR, Holdford TR. The risk of determining risk with multivariable models. Ann Intern Med 1993; 118:201-210
17. 17 Kollef MH, Sherman G, Ward S, et al. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest 1999; 115:462-474
18. 18 Luna CM, Vujacich P, Neiderman MS, et al. Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia. Chest 1997; 111:676-685
19. 19 Alvarez-Lerma F. Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit: ICU-Acquired Pneumonia Study Group. Intensive Care Med 1996; 22:387-394
20. 20 Rello J, Gallego M, Mariscal D, et al. The value of routine microbial investigation in ventilator-associated pneumonia. Am J Respir Crit Care Med 1997; 156:196-200
21. 21 Kollef MH, Ward S. The influence of mini-BAL cultures on patients outcomes: implications for the antibiotic management of ventilator-associated pneumonia. Chest 1998; 113: 412-420
22. 22 Kollef MH. Ventilator-associated pneumonia: a multivariate analysis. JAMA 1993; 270:1965-1970
23. 23 Rello J, Ausina V, Ricart M, et al. Impact of previous antimicrobial therapy on the etiology and outcome of ventilator-associated pneumonia. Chest 1993; 104:1230-1235
24. 24 Fagon JY, Chastre J, Domart Y, et al. Nosocomial pneumonia in patients receiving continuous mechanical ventilation: prospective analysis of 52 episodes with the use of a protected specimen brush and quantitative culture technique. Am Rev Respir Dis 1989; 139:877-884
25. 25 Rello J, Torres A, Ricart M, et al. Ventilator-associated pneumonia by Staphylococcus aureus: comparison of methicillin-resistant and methicillin-sensitive episodes. Am J Respir Crit Care Med 1994; 150:1545-1549
26. 26 Heyland DK, Cook DJ, Griffith L, et al. The attributable morbidity and mortality of ventilator-associated pneumonia in critically ill patients. Am J Respir Crit Care Med 1999; 159:1249-1256
27. 27 Mosconi PM, Langer M, Cigada M, et al. Epidemiology and risk factors of pneumonia in critically ill patients. Eur J Epidemiol 1991; 7:320-327
28. 28 Fagon JY, Chastre J, Hance AJ, et al. Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay. Am J Med 1993; 94:281-288
29. 29 Torres A, Gatell JM, Aznar E, et al. Reintubation increases the risk of pneumonia in patients needing mechanical ventilation. Am J Respir Crit Care Med 1995; 152:137-141
30. 30 Gopalakrishman R, Hawley HB, Czachor JS, et al. Stentrophomonas maltophilia infection and colonization in the intensive care units of two community hospitals: a study of 143 patients. Heart Lung 1999; 28:134-141
31. 31 Rello J, Sa-Borges M, Correa H, et al. Variations in etiology of ventilator-associated pneumonia across four treatment sites: implications for antimicrobial prescribing practices. Am J Respir Crit Care Med 1999; 160:608-613
32. 32 Salata RA, Lederman MM, Shales DM, et al. Diagnosis of nosocomial pneumonia in intubated, intensive care unit patients. Am Rev Respir Dis 1987; 135:426-432
33. 33 Meduri GU. Ventilator-associated pneumonia in patients with respiratory failure: a diagnostic approach. Chest 1990; 97: 1208-1219
34. 34 Torres A, Anzar R, Gatell JM, et al. Incidence, risk, and prognosis factors of nosocomial pneumonia in mechanically ventilated patients. Am Rev Respir Dis 1990; 142:523-528
35. 35 Valles J, Artigas A, Rello J, et al. Continuous aspiration of subglottic secretions in preventing ventilator-associated pneumonia. Ann Intern Med 1995; 122:179-186
36. 36 Torres A, El-Ebiary M, Padro L, et al. Validation of different techniques for the diagnosis of ventilator-associated pneumonia: comparison with immediate postmortem pulmonary biopsy. Am J Respir Crit Care Med 1994; 149:324-331
37. 37 Meduri GU, Beals DH, Maijub AG, et al. Protected bronchoalveolar lavage: a new bronchoscopic technique to retrieve uncontaminated distal airway secretions. Am Rev Respir Dis 1991; 143:855-864
38. 38 Dotson RG, Pingleton SK. The effect of antibiotic therapy on recovery of intercellular bacteria from bronchoalveolar lavage in suspected ventilator-associated pneumonia. Chest 1993; 103:541-546
39. 39 Torres A, Martos A,. Puig de la Bellacasa J, et al. Specificity of bronchoalveolar lavage in mechanically ventilated patients. Am Rev Respir Dis 1993; 147:952-957
40. 40 Niederman MS, Torres A, Summer W. Invasive diagnostic testing is not needed routinely to manage suspected ventilator-associated pneumonia. Am J Respir Crit Care Med 1994; 150:565-569